CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mnemosyne Pharmaceuticals is pleased to announce the recruitment of 20-year neuroscience R&D veteran Timothy Piser, Ph.D., to the leadership team. He will serve as Chief Scientific Officer (CSO). In addition, effective immediately, Mnemosyne has changed its name to Luc Therapeutics, Inc. (pronounced ‘Luke’) to better reflect the Company’s ongoing corporate evolution, and its overall synaptic plasticity-oriented drug development strategy. The new Luc Therapeutics will be headquartered in Cambridge, MA.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
